Trial intelligence / Profile preview

Therapeutic Efficacy of SB Flavon in Advanced HBV-related Cirrhosis and HCC

NCT07084948Phase 4Completed

Start
Nov 2015
Primary completion
Oct 2025
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of Vasoclean in hepatitis B virus infection, Cirrhosis, hepatocellular carcinoma (HCC). Started Nov 2015; status: completed.

02

Drugs

Vasoclean
03

Conditions

hepatitis B virus infectionCirrhosishepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT07084948.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07084948.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call